Niveda Sundararaman

Niveda Sundararaman

Auto-generated profile, based on publicly available information

Niveda Sundararaman

Advanced Clinical Biosystems Research Institute, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA (N.S., S.J.P., J.E.V.E.).

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2020 in Journal of the American Society for Mass Spectrometry
Verified
Journal Article
Closed access
NSNiveda Sundararaman
Niveda Sundararaman
JGJames Go
James Go
ARAaron Robinson
Aaron Robinson
JMJosé M. Mato
José M. Mato
SLShelly C. Lu
Shelly C. Lu
VVVidya Venkatraman
Vidya Venkatraman

25 January 2023 in Journal of Proteome Research
Verified
Journal Article
Closed access
NSNiveda Sundararaman
Niveda Sundararaman
ABArchana Bhat
Archana Bhat
VVVidya Venkatraman
Vidya Venkatraman
ABAleksandra Binek
Aleksandra Binek
ZDZachary Dwight
Zachary Dwight
JEJennifer Van Eyk
Jennifer Van Eyk

24 February 2025 in Journal of Proteome Research
Verified
Journal Article
Closed access
MVManasa Vegesna
Manasa Vegesna
NSNiveda Sundararaman
Niveda Sundararaman
ABAjay Bharadwaj
Ajay Bharadwaj
KWKirstin Washington
Kirstin Washington
RPRakhi Pandey
Rakhi Pandey
JEJennifer Van Eyk
Jennifer Van Eyk

Verified
Journal Article
Open access
PDF file
NANethika R. Ariyasinghe
Nethika R. Ariyasinghe
DGDivya Gupta
Divya Gupta
SESean S Escopete
Sean S Escopete
DRDeepika Rai
Deepika Rai
ASAleksandr Stotland
Aleksandr Stotland
SPSarah J Parker
Sarah J Parker
The prevalence of cardiovascular disease varies with sex, and the impact of intrinsic sex-based differences on vasculature is not well understood. Animal models can provide important insights into some aspects of human biology; however, not all discoveries in animal systems translate well to humans. To explore the impact of chromosomal sex on proteomic phenotypes, we used iPSC-derived vascular smooth muscle cells from healthy donors of both sexes to identify sex-based proteomic differences and their possible effects on cardiovascular pathophysiology. Our analysis confirmed that differentiated cells have a proteomic profile more similar to healthy primary aortic smooth muscle cells than iPSCs. We also identified sex-based differences in iPSC-derived vascular smooth muscle cells in pathways related to ATP binding, glycogen metabolic process, and cadherin binding as well as multiple proteins relevant to cardiovascular pathophysiology and disease. Additionally, we explored the role of autosomal and sex chromosomes in protein regulation, identifying that proteins on autosomal chromosomes also show sex-based regulation that may affect the protein expression of proteins from autosomal chromosomes. This work supports the biological relevance of iPSC-derived vascular smooth muscle cells as a model for disease, and further exploration of the pathways identified here can lead to the discovery of sex-specific pharmacological targets for cardiovascular disease.

31 July 2026 in Circulation Research
Verified
Journal Article
Closed access
MMMin Ma
Min Ma
YLYingyi Lian
Yingyi Lian
ESErfei Shang
Erfei Shang
CXChao Xue
Chao Xue
MWMaosheng Wei
Maosheng Wei
Jun  QuJun Qu
Jun Qu
Cardiovascular function is tightly linked to tissue architectures, where the spatial organization of cells, extracellular matrix (ECM), vascular networks, and remodeling processes governs physiological performance and disease progression. Spatial proteomics has, therefore, emerged as a powerful framework for understanding cardiovascular biology and cardiovascular disease mechanisms by revealing spatially organized protein regulation across various physiological and pathological states. In this review, we focus on spatial proteomics strategies most relevant to cardiovascular research and discuss their applications through representative examples. These approaches can be broadly categorized into region-of-interest–based methods, which enable precise characterization of localized cellular heterogeneity, and tissue mapping strategies, which capture spatial organization and biologically relevant region-to-region variability across larger tissue domains. In addition, spatial proteomics platforms differ in their capacity for targeted or untargeted protein analysis, influencing both proteome coverage and their suitability for hypothesis-driven versus discovery-based studies. We evaluate the strengths and limitations of state-of-the-art technologies across 3 key parameters, molecular depth, spatial coverage, and spatial resolution, and discuss how these parameters shape study design and biological understanding. Building on these considerations, we argue that a comprehensive understanding of cardiovascular tissue biology requires spatial proteomics strategies that capture both localized molecular details and spatial organization across large tissue areas, as neither alone is sufficient to explain complex tissue behavior. We propose an integrated workflow in which untargeted, whole-tissue mapping of thousands of proteins is first used to unbiasedly discover spatial patterns and generate hypotheses by identifying candidate regions and proteins of interest, followed by hypothesis testing and validation using high-precision region-of-interest–based proteomics and targeted protein imaging. This sequential framework leverages the complementary strengths of tissue-wide mapping and region-of-interest–based approaches to provide multiscale, mechanistic insights into spatially organized disease processes. Finally, we discuss emerging directions that are poised to expand the scope of spatial proteomics in cardiovascular research.

21 April 2025 in Journal of Proteome Research
Verified
Journal Article
Closed access
SSSaeed Seyedmohammad
Saeed Seyedmohammad
ARAlejandro Rivas
Alejandro Rivas
MZMaxim Zhgamadze
Maxim Zhgamadze
AHAli Haghani
Ali Haghani
SKSimion Kreimer
Simion Kreimer
JEJennifer Van Eyk
Jennifer Van Eyk